The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first prescription medicine ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...